Trade Mark Journal No.2026/034 21 August 2026

WO0000001931098 (5)

Office of origin: Republic of Korea

Date of International Registration:6 July 2026
Date of designation in the UK: 6 July 2026
Image for mark 1931098 PEBLYSMA

International priority date claimed: 15 January 2026 (Republic of Korea) (4020260009199)
Class 5
Pharmaceutical preparations for the treatment of cancer; medicines for human purposes.

CELLTRION, INC.

Representative: JIDAM IP LAW FIRM, A-201, U Space 2, 670, Deawangpangyo-ro,, Bundang-gu, Seongnam-si, Gyeonggi-do, REPUBLIC OF KOREA